Description:
There were over 100 billion IVD procedures in 2021. These represent sources of revenue for IVD companies and laboratories, but they also represent gateway activities to a broad range of healthcare events including surgeries, pharmaceutical prescriptions imaging procedures and physician office visits. Finding information for procedure volumes can be difficult as companies do not publish this information. For this reason, Kalorama has published IVD Procedure Volumes, 2021-2026, a guide where procedures on a wide variety of tests are estimated based on information in public sources, Kalorama databases, revenue estimates, country medical authorities and medical journals. This comprehensive report analyzes global trends in IVD procedural volume.
This comprehensive report provides essential calculations and estimates of both current and future volumes for a wide range of diagnostic tests, including pricing analysis. It is an indispensable tool for new market entrants and existing product marketers looking to understand the market opportunity.
Report Highlights:
- IVD Test Procedure Volume and Pricing Estimates for Key Segments:
- Worldwide IVD Market and Test Volume
- Point-of-Care (POC) Market and Test Volume
- Clinical Chemistry Market and Test Volume
- Molecular Market and Test Volume
- Hematology Market and Test Volume
- Coagulation Market and Test Volume
- Microbiology Market and Test Volume
- Blood Banking Market and Test Volume
- COVID-19 Market and Test Volume
- Histology/Cytology Market and Test Volume
- Immunoassay Market and Test Volume
IVD Testing Segments and Global Markets:
- The report includes profiles of top IVD market competitors, detailing procedural volume by type wherever possible.
- Analysis covers point-of-care and laboratory tests categorized by testing technology, with clinical chemistry, hematology, and immunoassays leading in the number of tests performed worldwide.
- Molecular assays are highlighted for their growing procedural volume and sales, especially influenced by the pandemic, though they represent a smaller portion of total IVD activities.
- Conventional microbiology, coagulation (hemostasis), histology, and cytology are among the most widely employed IVD testing technologies.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: IVD Procedural Volume [excluding blood glucose tests], 2021-2026 (millions)
| Item/Year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR |
| POC Self Testing | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| POC Professional Tests | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Clinical Chemistry | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Immunoassays | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Mass Spectrometry (Immuno) | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Molecular | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Hematology | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Coagulation | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Conventional Microbiology | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Mass Spectrometry (Micro) | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Blood Grouping/Typing | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Histology/Cytology | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Total | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
Source: Kalorama Information
